Therapeutic serum concentration monitoring for nontuberculous mycobacteria patients
Not Applicable
- Conditions
- Pulmonary nontuberculous mycobacteriosis
- Registration Number
- JPRN-UMIN000041053
- Lead Sponsor
- Meiji Pharmaceutical University
- Brief Summary
1. 73 patients were enrolled. The primary endpoint were determined in 71 patients (2 patients lost to follow-up). The inclusion has been completed. 2. Number of measurements 71 3. Survey results Quantitative determination of all samples have been completed.. 4. Others Pharmacokinetic analysis has been completed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 73
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects who are pregnant or breastfeeding 2)Subjects whose treatment start date are unknown 3)Subjects who are judged as inadequate by physicians
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method